Bruker Posts Fifth Straight Quarter of BSI Book-to-Bill Above 1

As seen on the 24/7 Wall St. homepage on November 4, 2026.

In the third quarter, we achieved very significant margin expansion and non-GAAP EPS growth, driven by our focus on cost discipline and execution. Bruker's positive booking trends continued with the fifth consecutive quarter of Bruker Scientific Instruments (BSI) book-to-bill greater than one.

Five straight quarters of orders outpacing shipments at the scientific instruments arm means the $8.6 billion lab-tools maker is building backlog while cost cuts do the heavy lifting on earnings. That combination is what investors in the group have been waiting to see.

Continue ReadingShow less

Bruker's BSI scientific instruments division has booked more orders than it shipped for five straight quarters, so demand is running ahead of delivery and future revenue is already committed.

CEO Frank H. Laukien credited cost discipline and operational execution for the third quarter's margin expansion and non-GAAP EPS growth.

Sponsored

The backlog build cuts near-term revenue uncertainty, since each quarter opens with more committed work than the last one closed with.

Keep an eye on the stock for a sixth quarter above one and any sign that cost savings are running out of room.

Mentioned: BRKR, BRKRP, BRUKP